EMITF - Elbit Imaging Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.60
-0.10 (-5.88%)
As of 11:12AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.70
Open1.74
Bid1.51 x 800
Ask1.60 x 200
Day's Range1.54 - 1.75
52 Week Range1.54 - 3.23
Volume17,798
Avg. Volume12,096
Market Cap13.731M
Beta (3Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-8.32
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2008-05-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    ELBIT IMAGING LTD. ANNOUNCES THAT THE CMS HAS UPDATED THE REIMBURSMENT CODE FOR INSIGHTEC'S MRGFUS TREATMENTS

    Tel Aviv, Israel, Nov. 13, 2018 -- Elbit Imaging Ltd. (the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press release dated December 14, 2017, that the.

  • GlobeNewswire6 days ago

    ELBIT IMAGING ANNOUNCES SALE OF ADDITIONAL ELBIT MEDICAL SHARES

    Tel Aviv, Israel, Nov. 08, 2018 -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today that the Company has completed the sale of an additional.

  • GlobeNewswire6 days ago

    ELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES I

    Tel Aviv, Israel, Nov. 08, 2018 -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press releases dated July 18, 2018, October.

  • GlobeNewswire7 days ago

    ELBIT IMAGING ANNOUNCES UPDATE REGARDING THE TERM SHEET TO SELL THE PLOT IN CHENNAI, INDIA

    Elbit Imaging Ltd. (the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press release dated October 18, 2018, regarding the updated term sheet for the sale of its 50% stake in a 74.7 acre plot in Chennai, India (the "Plot") for a total consideration of approximately Euro 12.7 million (the "Consideration"), that the closing date of the transaction has been extended to December 20, 2018 (the "Closing Date"). In addition, the parties agreed that the buyer of the Plot will have to deposit no later than the end November, non-refundable amount of 10 Crores (approximately USD 1.37 million (on account of the Consideration)) in order to maintain its right to complete the transaction until the Closing Date.

  • GlobeNewswire19 days ago

    ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL HAS RASIED USD50 MILLION IN AN IPO IN THE UNITED STATES

    Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (“Elbit”) announced today, further to its press releases dated September 29, 2018 and October 17, 2018 on the filing by Gamida Cell Ltd. (“Gamida”) of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission in connection with a proposed initial public offering of its ordinary shares in the United States and application to list its ordinary shares on NASDAQ (the "IPO"), that on October 26, 2018 Gamida completed the pricing for the IPO and for the listing of 6.25 million of its ordinary shares. The price set in the pricing procedure is eight (8) dollars per share, a price that reflect a post-money valuation of Gamida of approximately 215 million dollars.

  • GlobeNewswire20 days ago

    ELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES I

    Tel Aviv, Israel, Oct. 25, 2018 -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press releases dated July 18, 2018 and.

  • GlobeNewswire27 days ago

    ELBIT IMAGING LTD. ANNOUNCES ADDITIONAL BUYBACK OF NOTES SERIES I

    Tel Aviv, Israel, Oct. 18, 2018 -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press releases dated July 18, 2018 and.

  • GlobeNewswire27 days ago

    ELBIT IMAGING ANNOUNCES UPDATE REGARDING THE TERM SHEET TO SELL THE PLOT IN CHENNAI, INDIA

    Elbit Imaging Ltd. (the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press release dated July 5, 2018, regarding the signing of a term sheet for the sale of its 50% stake in a 74.7 acre plot in Chennai, India (the "Plot" and the "Term Sheet", respectively), that the closing date of the transaction has been extended to November 10, 2018. The consummation of the transaction is subject to satisfactory completion of the due diligence process and the execution of a definitive agreement and the fulfillment of certain conditions precedent. At this stage, there is no certainty that the transaction will be completed.

  • GlobeNewswire28 days ago

    ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL HAS MADE A PUBLIC FILING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION IN CONNECTION WITH A PROPOSED IPO IN THE UNITED STATES

    Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (“Elbit”) announced today, further to its press release dated September 29, 2018 on the filing by Gamida Cell Ltd. (“Gamida”) of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission in connection with a proposed initial public offering of its ordinary shares in the United States and application to list its ordinary shares on NASDAQ (the "IPO"), that on October 17, 2018 Gamida published a draft Form F-1 that includes the main terms of the proposed IPO on which it will begin a road show for investors in the United States. According to the draft Form F-1, Gamida intends to raise between 50 and 60 million dollars through an issuance of 3.6 million shares at a price per share of between 13 to 15 dollars.

  • GlobeNewswirelast month

    ELBIT IMAGING LTD. ANNOUNCES NOTES BUYBACK

    Tel Aviv, Israel, Oct. 11, 2018 -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today, further to its press release dated July 18, 2018 regarding.

  • GlobeNewswirelast month

    ELBIT IMAGING ANNOUNCES RESULTS OF ITS ANNUAL AND SPECIAL GENERAL MEETING OF SHAREHOLDERS

    Tel Aviv, Israel, Oct. 04, 2018 -- Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced today that at its Annual and Special General Meeting of.

  • GlobeNewswirelast month

    ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL MADE A PUBLIC FILLING TO THE U.S. SECURITIES AND EXCHANGE COMMISSION IN CONNECTION WITH A PROPOSED IPO IN THE UNITED STATES

    Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) (“Elbit” or the “Company”) announced today that Gamida Cell Ltd. (“Gamida”) filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission in connection with a proposed initial public offering of its ordinary shares in the Unites States. Gamida Cell has applied to list its ordinary shares on the Nasdaq Global Market under the ticker symbol “GMDA”.

  • GlobeNewswire2 months ago

    ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL FOR EXABLATE NEURO COMPATIBILITY WITH SIEMENS HEALTHINEERS MRI SCANNERS

    Tel Aviv, Israel, Sept. 26, 2018-- Elbit Imaging Ltd. announced today that Insightec Ltd. informed that the U.S. Food and Drug Administration has approved Exablate Neuro™ compatibility for the MRI Scanners ...

  • GlobeNewswire2 months ago

    ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL HAS APPOINTED A NEW CHAIRMAN OF THE BOARD

    Tel Aviv, Israel, Sept. 20, 2018-- Elbit Imaging Ltd. announced today that Gamida Cell Ltd., in which the Company indirectly holds approximately 15% of its issued and paid up share capital, has appointed ...

  • GlobeNewswire2 months ago

    ELBIT IMAGING ANNOUNCES COMPLETION OF THE FIRST STAGE FOR THE SALE OF UP TO 50% OF THE SHARE CAPITAL OF ELBIT MEDICAL LTD.

    Tel Aviv, Israel, Sept. 06, 2018-- Elbit Imaging Ltd. announced today, further to its press release dated August 8, 2018, that it has completed the first stage of the transaction and sold 11,574,146 shares ...

  • GlobeNewswire2 months ago

    ELBIT IMAGING ANNOUNCES AN UPDATED EVALUATION REFERRING TO ELBIT MEDICAL TECHNOLOGIES

    Tel Aviv, Israel, Sept. 06, 2018-- Elbit Imaging Ltd. announced today, further to its press release dated June 28, 2018, that Edison Investment Research Ltd. published an updated evaluation of its subsidiary, ...

  • GlobeNewswire2 months ago

    ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL SUBMITTED CONFIDENTIAL FILINGS AS PART OF PURSUING VARIOUS ALTERNATIVES FOR RAISING CAPITAL

    Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today that Gamida Cell Ltd. ("Gamida"), in which the Company indirectly holds approximately 16% of its issued and paid up share capital (approx. 8% on a fully diluted basis), is pursuing various alternatives for raising additional capital, including an Initial Public Offering of its ordinary shares in the Unites States, for which it has confidentially submitted draft filings of a registration statement to the U.S. Securities and Exchange Commission.. The Company holds approximately 89% of the share capital of Elbit Medical Technologies Ltd. (TASE:EMTC-M) (approximately 58% on a fully diluted basis) which, in turn, holds approximately 18% of the share capital in Gamida (approximately 13% on a fully diluted basis).

  • ACCESSWIRE4 months ago

    Elbit Imaging Ltd. Announces that Insightec Receives FDA Approval to Initiate Clinical Study of MR-Guided Focused Ultrasound to Treat Patients with Alzheimer's Disease

    TEL AVIV, ISRAEL / ACCESSWIRE / July 26, 2018 / Elbit Imaging Ltd. (TASE: EMITF, NASDAQ: EMITF) (" Elbit " or the " Company ") announced today, further to its press release dated March ...

  • ACCESSWIRE4 months ago

    Elbit Imaging Announces Several Steps Intended to Strengthen its Financial Position

    The Company has entered into a Non-Binding Memorandum of Understanding ("MOU") with the Exigent Capital Group ("Exigent") for the sale of between 11,574,146 ordinary shares of Elbit Medical Technologies Ltd. (" Elbit Medical") (5% of its outstanding share capital) and 115,741,467 ordinary shares of Elbit Medical (50% of its outstanding share capital) (the "Maximum Quantity") for a price per share of NIS 0.96 ($0.26 based on the NIS-US$ representative rate of exchange as of today) ("Per Share Price"). Under the terms of the MOU, Exigent is to purchase 11,574,146 shares of Elbit Medical within 30 days of signing a definitive agreement between the parties (the "Initial Closing").

  • ACCESSWIRE4 months ago

    Elbit Imaging Announces Term Sheet In Respect Of A Plot In Chennai, India

    TEL AVIV, ISRAEL / ACCESSWIRE / July 5, 2018 / Elbit Imaging Ltd. ("EI" or the "Company") (EMITF.TA) (EMITF) announced today, further to its press release dated August 2, 2016 (regarding Elbit Plaza India Real Estate Holdings Limited ("EPI") (a jointly controlled subsidiary in which the Company and its subsidiary, Plaza Centers N.V. ("Plaza") each hold a 50% stake) signing a Joint Development Agreement with a local Indian partner (the "Buyer") relating to its 74.7 acre plot in Chennai, India (the "Plot")) that EPI has signed a term sheet with the Buyer in respect to the sale of EPI's subsidiary ("SPV") that holds the Plot (the "Term Sheet"). Under the terms of the Term Sheet, the Buyer shall have a period of 60 (sixty) days to undertake a due diligence process solely with respect to the SPV, following which definitive agreements for the sale of the SPV, in consideration for INR 110 Crores (approximately €13.8 million, subject to adjustment with respect to the previous amount deposited and the existing cash in the SPV) shall be signed and closing shall take place on the same day.

  • ACCESSWIRE4 months ago

    Elbit Imaging Ltd. Announces Israeli Court Ruling In Regards to VAT Assessments

    TEL AVIV, ISRAEL / ACCESSWIRE / July 2, 2018 / Elbit Imaging Ltd. (EMITF.TA) (EMITF) ("Elbit" or the "Company") announced today that an Israeli court issued a decision in a lawsuit brought by the Company against the Israeli Tax Authority relating to VAT assessments issued to the Company and relating to the period from April 2006 to June 2011. In the decision, the court accepted in part the Israeli Tax Authority's position and ruled that the Company should have deducted input tax at rates lower than those actually deducted by the Company. Accordingly, the Company is required to pay the Israeli Tax Authority a payment of approximately NIS 16.5 million (excluding interest and linkage differentials) for the relevant period.

  • ACCESSWIRE5 months ago

    Elbit Imaging Ltd. Announces Receipt of Nasdaq Continued Listing Deficiency Notice

    TEL AVIV, ISRAEL / ACCESSWIRE / June 28, 2018 / Elbit Imaging Ltd. (EMITF.TA) (EMITF) ("Elbit" or the "Company") announced today that that it has received written notification from the Nasdaq Stock Market ("Nasdaq") dated June 26, 2018, indicating that the Company is no longer in compliance with the continued listing requirement under Nasdaq Listing Rule 5450(b)(3)(C) because the market value of its publicly held shares ("MVPHS") was below $15,000,000 for 30 consecutive business days. Under Nasdaq rules, publicly held shares is defined as shares not held directly or indirectly by an officer, director or any person who is the beneficial owner of more than 10% of the total shares outstanding of the Company. Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), the applicable grace period to regain compliance is 180 calendar days, or until December 24, 2018.